Memory CD4 T-cells play a key role in host defense as well as the triggering and maintaining of inflammation. The triggering of the costimulatory signals plays a central role in the generation of effective immune responses. The costimulatory signals can be provided by a number of accessory molecules. Of the costimulatory molecules, CD29/VLA, CD26, and CD27 have been established by this group. CD29/VLA and CD26 are preferentially expressed on CD4 memory T-cells and play an important role in the costimulation, function, and migration of memory T-cells. Much remains to be clarified regarding the complex functions of CD29/VLA and CD26 in signal transduction and the subsequent effects upon T-cell function and cell migration. The major goal of this application is to determine the immunoregulatory circuits in man.
The specific aims of this application are: 1) The molecular basis of CD29/VLA in T-cell costimulation, signaling and T-cell function. They will define the structural basis of Cas-L tyrosine phosphorylation and FAK activation and define the role of Cas-L in CD29/VLA-mediated cytokine production and gene expression. Moreover, the role of Cas-L in T-cell migration will be defined. 2) The molecular basis of CD26/DPPIV in T-cell function and costimulation. The role of CD26/DPPIV in T-cell migration, the precise characteristics of the binding of ADA to CD26, and the functional significance of ADA in T-cell activation will be defined. In addition, the structure and function of the ligand of CD26 other than ADA will be defined. 3), The molecular and cellular defects in patients with autoimmune diseases. Analysis of VLA-mediated costimulation in patients with autoimmune diseases will be performed. Moreover, the expression and function, of Cas-L, and FAK as well as the migratory activity of T-cells in autoimmune diseases will be determined. In addition, the level of CD26/DPPIV in serum/plasma and its correlation with clinical complications in autoimmune diseases will be defined. The study will not only provide new insights into understanding of the mechanisms of T-cell activation and migration, but will also provide new insights into understanding the precise molecular mechanisms of immune abnormalities found in various autoimmune diseases and will lead to the development of rational therapy for the manipulation of the abnormalities found in such diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
7R01AR033713-18
Application #
6549733
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Gretz, Elizabeth
Project Start
1985-07-01
Project End
2003-06-30
Budget Start
2001-10-01
Budget End
2002-06-30
Support Year
18
Fiscal Year
2001
Total Cost
$227,703
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Sasaki, Takahiro; Iwata, Satoshi; Okano, Hirotaka James et al. (2005) Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia. Stroke 36:2457-62
Kobayashi, H; Hosono, O; Iwata, S et al. (2004) The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation. Clin Exp Immunol 137:101-8
Ohnuma, Kei; Yamochi, Tadanori; Uchiyama, Masahiko et al. (2004) CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. Proc Natl Acad Sci U S A 101:14186-91
Kobayashi, Seiji; Ohnuma, Kei; Uchiyama, Masahiko et al. (2004) Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation. Blood 103:1002-10
Sato, K; Aytac, U; Yamochi, T et al. (2003) CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors. Br J Cancer 89:1366-74
Ishii, Tomonori; Ohnuma, Kei; Murakami, Akikazu et al. (2003) SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production. J Immunol 170:3653-61
Miyake-Nishijima, Rikako; Iwata, Satoshi; Saijo, Shinobu et al. (2003) Role of Crk-associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans. Arthritis Rheum 48:1890-900
Iwata, Satoshi; Kobayashi, Hiroshi; Miyake-Nishijima, Rikako et al. (2002) Distinctive signaling pathways through CD82 and beta1 integrins in human T cells. Eur J Immunol 32:1328-37
Dang, N H; Morimoto, C (2002) CD26: an expanding role in immune regulation and cancer. Histol Histopathol 17:1213-26
Ohnuma, Kei; Ishii, Tomonori; Iwata, Satoshi et al. (2002) G1/S cell cycle arrest provoked in human T cells by antibody to CD26. Immunology 107:325-33

Showing the most recent 10 out of 100 publications